Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 6/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL1532390 | 0.98 | ALDH1A1 (0.78) | ALDH1A1LMNACA2RECQLTDP1 | |
| Sulfuric Acid SCHEMBL4227582 | 0.96 | ALDH1A1 (0.75) | ALDH1A1LMNACA2RECQLTDP1 | |
| Sulfuric Acid SCHEMBL27976207 | 0.96 | ALDH1A1 (0.75) | ALDH1A1LMNACA2RECQLTDP1 | |
| Sulfuric Acid SCHEMBL4227587 | 0.96 | ALDH1A1 (0.75) | ALDH1A1LMNACA2RECQLTDP1 | |
| Sulfuric Acid SCHEMBL27985111 | 0.94 | ALDH1A1 (0.72) | ALDH1A1LMNACA2RECQLTDP1 | |
| SCHEMBL14057962 | 0.92 | ALDH1A1 (0.75) | ALDH1A1LMNACA2RECQLTDP1 | |
| Sulfuric Acid SCHEMBL11449229 | 0.90 | LMNA (0.65) | ALDH1A1LMNACA2RECQLTP53 | |
| SCHEMBL10822529 | 0.89 | ALDH1A1 (0.95) | ALDH1A1LMNACA2TDP1TP53 | |
| Sulfuric Acid SCHEMBL27761379 | 0.87 | ALDH1A1 (0.62) | ALDH1A1LMNACA2RECQLTP53 | |
| Sulfuric Acid SCHEMBL27761378 | 0.87 | ALDH1A1 (0.62) | ALDH1A1LMNACA2RECQLTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119843345-A | Electrolytic etching solution, electrolytic etching method, metal-plastic composite material and electronic equipment | 比亚迪股份有限公司 | 2025-04-18 | — | — | CN | disclosed |
| CN-117154530-B | High-power VCSEL laser and manufacturing method thereof | 江苏博睿光电股份有限公司 | 2024-02-02 | — | — | CN | disclosed |
| US-20230405025-A1 | CANNABINOID-CONTAINING COMPOSITIONS AND USE FOR TREATING AND PREVENTING DISEASES | Max Biology Co. Ltd. (KH) | 2023-12-21 | — | — | US | disclosed |
| CN-117154530-A | High-power VCSEL laser and manufacturing method thereof | 江苏博睿光电股份有限公司 | 2023-12-01 | — | — | CN | disclosed |
| CN-116940349-A | Cannabinoid-containing compositions and uses for the treatment and prevention of diseases | 麦氏生物科技有限公司 | 2023-10-24 | — | — | CN | disclosed |
| EP-4225298-A1 | CANNABINOID-CONTAINING COMPOSITIONS AND USE FOR TREATING AND PREVENTING DISEASES | MAX BIOLOGY CO. LTD. (KH) | 2023-08-16 | — | — | EP | disclosed |
| CN-110484945-B | Electroplating solution and method for electroplating shell of battery by using same | 福建南平南孚电池有限公司 | 2021-06-15 | — | — | CN | disclosed |
| CN-110106535-B | Neutral tin plating additive | 广东比格莱科技有限公司 | 2020-03-24 | — | — | CN | disclosed |
| CN-106637312-A | Copper plating solution for plate roller and preparation method of copper plating solution | 龙游运申制版有限公司 | 2017-05-10 | — | — | CN | disclosed |
| EP-2274460-B2 | ADHESION PROMOTION OF METAL TO LAMINATE WITH A MULTI-FUNCTIONAL COMPOUND | ENTHONE (US) | 2016-08-31 | — | — | EP | disclosed |
| US-5536743-A | Intravaginal treatment of vaginal infections with buffered metronidazole compositions | CURATEK PHARMACEUTICALS LIMITED PARTNERSHIP (US) | 1996-07-16 | — | — | US | disclosed |
| US-5472631-A | Applying mixture of surfactant and vegetable or mineral oil to paint brush bristles and working it in, then washing with water | HARRIS JACK W (US) | 1995-12-05 | — | — | US | disclosed |
| EP-0404376-B1 | Buffered metronidazole compositions for intravaginal treatment of vaginal infections | CURATEK PHARMACEUTICALS (US) | 1994-03-23 | — | — | EP | disclosed |
| US-5236627-A | COMPOSITIONS OF ELECTRICALLY CONDUCTIVE POLYMERS DERIVED FROM SUBSTITUTED OR UNSUBSTITUTED PYRROLE AND PROCESS FOR OBTAINING THEM | SOLVAY & CIE (SOCIETE ANONYME) (BE) | 1993-08-17 | — | — | US | disclosed |
| EP-0432686-A1 | Leather dyeing auxiliary composition | NIHON SURFACTANT KOGYO K.K. (JP) | 1991-06-19 | — | — | EP | disclosed |
| EP-0404376-A2 | Buffered metronidazole compositions for intravaginal treatment of vaginal infections | CURATEK PHARMACEUTICALS Limited Partnership (US) | 1990-12-27 | — | — | EP | disclosed |
| WO-1990014832-A1 | IMPROVED INTRAVAGINAL TREATMENT OF VAGINAL INFECTIONS WITH BUFFERED METRONIDAZOLE COMPOSITIONS | CURATEK PHARMACEUTICALS LIMITED PARTNERSHIP (US) | 1990-12-13 | — | — | WO | disclosed |
| EP-0137212-A2 | Ointment bases and ointments | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1985-04-17 | — | — | EP | disclosed |
| US-4508634-A | REMOVAL OF PAINT, GREASE AND DIRT | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-04-02 | — | — | US | disclosed |
| US-4017615-A | ESPECIALLY USEFUL FOR ANTIINFLAMMATORY TOPICAL CORTICOIDS | SYNTEX CORPORATION (PM) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230405025-A1 | CANNABINOID-CONTAINING COMPOSITIONS AND USE FOR TREATING AND PREVENTING DISEASES | CNR2, CNR1, FAAH | ALDH1A1 4180/4885LMNA 971/4885CA2 1767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.